Factors Affecting the Growth of the Neuromodulation Industry:

• Increasing Prevalence of Chronic Diseases and Disorders:

The burgeoning prevalence of chronic diseases and disorders, such as chronic pain, epilepsy, Parkinson's disease, and depression, are major factors driving the market growth. In line with this, the increasing utilization of neuromodulation devices, as they offer solutions by directly acting on the nervous system to alleviate symptoms and improve patients' quality of life, is favoring the market growth. Additionally, the growing availability of clinical evidence demonstrating the efficacy and safety of neuromodulation techniques, is enhancing the market growth. In confluence with this, the rising utilization of spinal cord stimulation (SCS) for managing chronic pain conditions that are resistant to conventional therapies, is bolstering the market growth.

Competitive Landscape:

• Abbott Laboratories

• Bioventus Inc.

• Boston Scientific Corporation

• Helius Medical Technologies

• Integer Holdings Corporation

• LivaNova PLC

• Medtronic plc

• MicroTransponder Inc.

• Neuronetics

• NeuroPace Inc.

• NeuroSigma Inc.

• Nevro Corp.

Request a sample copy of the report: https://www.imarcgroup.com/neuromodulation-market/requestsample

Neuromodulation Market Report Segmentation:

By Technology:

• Internal Neuromodulation

o Spinal Cord Stimulation (SCS)

o Deep Brain Stimulation (DBS)

o Vagus Nerve Stimulation (VNS)

o Sacral Nerve Stimulation (SNS)

o Gastric Electrical Stimulation (GES)

• External Neuromodulation

o Transcutaneous Electrical Nerve Stimulation (TENS)

o Transcranial Magnetic Stimulation (TMS)

o Others

By Biomaterial:

• Metallic Biomaterials

• Polymeric Biomaterials

• Ceramic Biomaterials

By Application:

• Parkinson's Disease

• Epilepsy

• Depression

• Dystonia

• Pain Management

• Others

Regional Insights:

• North America (United States, Canada)

• Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, Others)

• Europe (Germany, France, United Kingdom, Italy, Spain, Russia, Others)

• Latin America (Brazil, Mexico, Others)

• Middle East and Africa

Global Neuromodulation Market Trends:

The convergence of neuromodulation with artificial intelligence (AI) and machine learning (ML) technologies to enhance the precision, adaptability, and effectiveness of the therapies, is one of the major factors catalyzing the market growth. In addition to this, the exploration of non-invasive neuromodulation techniques, including focused ultrasound and transcranial magnetic stimulation (TMS), that offer a less invasive alternative to traditional implanted devices while potentially reducing risks and making the therapy accessible is fueling market growth. Furthermore, the expanding application of neuromodulation in treatments for addiction, obesity, and cognitive disorders is opening new opportunities for market growth.